Sr. FDA official calls Uniqure's Huntington's disease treatment a failure

Sr. FDA official calls Uniqure's Huntington's disease treatment a failure | ReutersSkip to main contentExclusive news, data and analytics for financial market professionalsLearn more aboutRefinitivMarch 5 (Reuters) - A senior FDA official called Uniqure's (UQ1.F), opens new tabexperimental Huntington's disease treatment a "failed product" in a conference call with media members on Thursday, casting further doubt on the prospects of its experimental gene therapy.Sign up here.Reporting by Mrinalika Roy in Ben ...